Community Events
HHP I&E Workshop
Evaluating Science through the Lens of Commercialisation


BMSIPO and SGInnovate came together to organise a panel on how pharmaceutical multinational corporations (MNCs) and investors evaluate innovative scientific projects from a commercialisation perspective.
Over 80 attendees from local biomedtechs, pharma companies, venture capitalists (VCs) and academics gathered to gain insights from the panel, which included Dr Nikhil Mutyal, Executive Director of Business Development and Licensing at MSD, Navjeewan Khosla, Partner at Novo Holdings Equity Asia, as well as Miemie Strydom, Director New Business Development at Johnson & Johnson Innovative Medicine, Asia Pacific.
The focus of the night’s conversation was on how big pharma approaches external innovation partnerships, namely with biomedtech start-ups. “There’s a reason why we’ve outsourced innovation. Biotech startups and universities are better equipped to drive discoveries, and that’s a model that will continue to exist,” emphasised Miemie Strydom.
A*STAR celebrates International Women's Day

From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.